Copyright
©The Author(s) 2019.
World J Crit Care Medl. Sep 11, 2019; 8(5): 59-71
Published online Sep 11, 2019. doi: 10.5492/wjccm.v8.i5.59
Published online Sep 11, 2019. doi: 10.5492/wjccm.v8.i5.59
Role | Biomarker |
Diagnosis | CRP, PCT, Ang 1, Ang 2 |
Severity of illness | CRP, PCT, Ang 1, Ang 2, Pro-ADM, Pro-ANP, Pro-VNP, SP-D, YKL-40, CCL 18, Endocan, NETs, FGF21, |
Clinical instability | CRP, PCT, NETs, FGF21 |
De-escalation antibiotic | PCT |
Prognostication | CRP, PCT, Ang 1, Ang 2, Pro-ADM, Pro-ANP, Pro-VNP, SP-D, YKL-40, CCL 18, NETs, FGF21 |
- Citation: Chalmers S, Khawaja A, Wieruszewski PM, Gajic O, Odeyemi Y. Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: The role of inflammatory biomarkers. World J Crit Care Medl 2019; 8(5): 59-71
- URL: https://www.wjgnet.com/2220-3141/full/v8/i5/59.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v8.i5.59